Your browser doesn't support javascript.
loading
The mechanism of action of Spi-B in the transcriptional activation of the interferon-α4 gene.
Miyazaki, Ryo; Saiga, Hiroyuki; Kato, Takumi; Bakoshi, Takamitsu; Senba, Rina; Shintani, An; Suzuki, Makiko; Takao, Kenjiro; Sasaki, Izumi; Iizuka, Akihiko; Sugiyama, Masanaka; Iwami, Nana; Fukuda-Ohta, Yuri; Hemmi, Hiroaki; Tanaka, Takashi; Miyake, Minoru; Kaisho, Tsuneyasu; Hoshino, Katsuaki.
Affiliation
  • Miyazaki R; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Saiga H; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Kato T; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Bakoshi T; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Senba R; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Shintani A; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Suzuki M; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Takao K; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Sasaki I; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Kimiidera, Wakayama 641-8509, Japan.
  • Iizuka A; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Science (IMS-RCAI), Yokohama, Kanagawa 230-0045, Japan.
  • Sugiyama M; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Science (IMS-RCAI), Yokohama, Kanagawa 230-0045, Japan; Laboratory for Immune Regulation, World Premier International Research Center Initiative, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871,
  • Iwami N; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Science (IMS-RCAI), Yokohama, Kanagawa 230-0045, Japan.
  • Fukuda-Ohta Y; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Kimiidera, Wakayama 641-8509, Japan.
  • Hemmi H; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Kimiidera, Wakayama 641-8509, Japan; Laboratory of Immunology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime 794-8555, Japan.
  • Tanaka T; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Science (IMS-RCAI), Yokohama, Kanagawa 230-0045, Japan.
  • Miyake M; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
  • Kaisho T; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Kimiidera, Wakayama 641-8509, Japan; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Science (IMS-RCAI), Yokohama, Kanagawa 230-0045, Japan; Laboratory for Immune Regulation, World Pre
  • Hoshino K; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Science (IMS-RCAI), Yokohama, Kanagawa 230-0045, Japan; Laboratory for Immune Regulation, World Premier International Research
Biochem Biophys Res Commun ; 525(2): 477-482, 2020 04 30.
Article in En | MEDLINE | ID: mdl-32111355
ABSTRACT
Plasmacytoid dendritic cells (pDCs) are characterized by an exclusive expression of nucleic acid sensing Toll-like receptor 7 (TLR7) and TLR9, and production of high amounts of type I interferon (IFN) in response to TLR7/9 signaling. This function is crucial for both antiviral immunity and the pathogenesis of autoimmune diseases. An Ets family transcription factor, i.e., Spi-B (which is highly expressed in pDCs) is required for TLR7/9 signal-induced type I IFN production and can transactivate IFN-α promoter in synergy with IFN regulatory factor-7 (IRF-7). Herein, we analyzed how Spi-B contributes to the transactivation of the Ifna4 promoter. We performed deletion and/or mutational analyses of the Ifna4 promoter and an electrophoretic mobility shift assay (EMSA) and observed an Spi-B binding site in close proximity to the IRF-7 binding site. The EMSA results also showed that the binding of Spi-B to the double-stranded DNA probe potentiated the recruitment of IRF-7 to its binding site. We also observed that the association of Spi-B with transcriptional coactivator p300 was required for the Spi-B-induced synergistic enhancement of the Ifna4 promoter activity by Spi-B. These results clarify the molecular mechanism of action of Spi-B in the transcriptional activation of the Ifna4 promoter.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Transcriptional Activation / Interferon-alpha / Proto-Oncogene Proteins c-ets Limits: Animals / Humans Language: En Journal: Biochem Biophys Res Commun Year: 2020 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Transcriptional Activation / Interferon-alpha / Proto-Oncogene Proteins c-ets Limits: Animals / Humans Language: En Journal: Biochem Biophys Res Commun Year: 2020 Type: Article Affiliation country: Japan